# Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM

> **NCT06038552** · — · COMPLETED · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 238 (actual)

## Conditions studied

- GIST, Malignant
- Liver Metastases

## Interventions

- **DRUG:** imatinib (IM)
- **PROCEDURE:** hepatic resection (HR)
- **PROCEDURE:** radiofrequency ablation (RFA)
- **PROCEDURE:** transarterial chemoembolization (TACE)

## Key facts

- **NCT ID:** NCT06038552
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-05-01
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2025-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06038552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06038552, "Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06038552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*